Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis

Journal of Cellular Physiology

Volumn 232, Issue 9, 2017, Pages 2359-2372

  Mittal, Rahul ^a   Debs, Luca H ^a   Patel, Amit P ^a   Nguyen, Desiree ^a   Patel, Kunal ^a   O'Connor, Gregory ^a   Grati, M'hamed ^a   Mittal, Jeenu ^a   Yan, Denise ^a   Eshraghi, Adrien A ^a   Deo, Sapna K ^a   Daunert, Sylvia ^a   Liu, Xue Zhong ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; CATECHOLAMINE; NEUROTRANSMITTER; RECEPTOR; SEROTONIN;

BLOOD FLOW; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; NUTRIENT; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; SYNTHESIS; ANIMAL; BACTERIUM; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; GASTROINTESTINAL DISEASE; HOST PATHOGEN INTERACTION; INNERVATION; INTESTINE INNERVATION; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; BACTERIA; BRAIN; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM DISEASES; ENTERIC NERVOUS SYSTEM; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; SEROTONIN;

EID: 85018467931     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25518     Document Type: Review

References (169)

1. Abraham WR. 2016. Going beyond the control of quorum-sensing to combat biofilm infections. Antibiotics (Basel) 5:3.
2. Abrass CK, O'Connor SW, Scarpace PJ, Abrass IB. 1985. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 135:1338–1341.
3. Araldi D, Ferrari LF, Levine JD. 2016. Gi-Protein coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming. Pain 157:1773–1782.
4. Arcaro I, Fischer BL, Lascola KM, Clark-Price SC. 2016. Effects of intravenous terbutaline on heart rate, arterial pressure and blood gases in anesthetized horses breathing air. Vet Anaesth Analg. In Press. doi: 10.1111/vaa.12377
5. Auteri M, Zizzio MG, Serio R. 2015. GABA and GABA receptors in the gastrointestinal tract: From motility to inflammation. Pharmacol Res 93:11–21.
6. Bailey MT, Karaszewski JW, Lubach GR, Coe CL, Lyte M. 1999. In vivo adaptation of attenuated Salmonella typhimurium results in increased growth upon exposure to norepinephrine. Physiol Behav 67:359–364.
7. Baumgart DC, Carding SR. 2007. Inflammatory bowel disease: Cause and immunobiology. Lancet 369:1627–1640.
8. Bearson BL, Bearson SM, Lee IS, Brunelle BW. 2010. The Salmonella enterica serovar Typhimurium QseB response regulator negatively regulates bacterial motility and swine colonization in the absence of the QseC sensor kinase. Microb Pathog 48:214–219.
9. Bender DA. 1983. Effects of a dietary excess of leucine on the metabolism of tryptophan in the rat: A mechanism for the pellagragenic action of leucine. Br J Nutr 50:24–32.
10. Berger M, Gray JA, Roth BL. 2009. The expanded biology of serotonin. Annu Rev Med 60:355–366.
11. Berlioz F, Maoret JJ, Paris H, Laburthe M, Farinotti R, Roze C. 2000. Alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line. J Pharmacol Exp Ther 294:466–472.
12. Berman S, Suyenobu B, Naliboff BD, Bueller J, Stains J, Wong H, Mandelkern M, Fitzgerald L, Ohning G, Gupta A, Labus JS, Tillisch K, Mayer EA. 2012. Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome. Neuroimage 4:1854–1863.
13. Bjurstöm H, Wang J, Ericsson I, Bengtsson M, Liu Y, Kumar-Mendu S, Issazadeh-Navikas S, Birnir B. 2008. GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 205:44–50.
14. Blais AS, Nadeau G, Moore K, Genois L, Bolduc S. 2016. Prospective pilot study of mirabegron in pediatric patients with overactive bladder. Eur Urol 16:182.
15. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, Liu K, Jakubzick C, Ingersoll MA, Leboeuf M, Stanley ER, Nussenzweig M, Lira SA, Randolph GJ, Merad M. 2009. Origin of the lamina propria dendritic cell network. Immunity 31:513–525.
16. Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, Shaughnessy E, Ben-Jonathan N. 2016. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene 35:3103–3113.
17. Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ. 2009. Mechanism for quinolinic acid cytotoxicity tin human astrocytes and neurons. Neurotox Res 16:77–86.
18. Burr RL, Jarrett ME, Cain KC, Jun SE, Heitkemper MM. 2009. Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome. Neurogastroenterol Motil 11:1148–1197.
19. Camilleri M. 2012. Mechanisms of disease: Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 367:1626–1635.
20. Castillo-Juárez I, Maeda T, Mandujano-Tinoco EA, Tomás M, Pérez-Eretza B, García-Contreras SJ, Wood TK, García-Contreras R. 2015. Role of quorum sensing in bacterial infections. World J Clin Cases 3:575–598.
21. Cervi AL, Lukewich MK, Lomax AE. 2014. Neural regulation of gastrointestinal inflammation: Role of the sympathetic nervous system. Auton Neurosci 182:83–88.
22. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ, Mayer EA. 2009. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2:149–159.
23. Choudhury BK, Shi XZ, Sarna SK. 2009. Norepinephrine mediates the transcriptional effects of heterotypic chronic stress on colonic motor function. Am J Physiol Gastrointest Liver Physiol 296:1238–1247.
24. Cloez-Tayarani I, Changeux JP. 2007. Nicotine and serotonin in immune regulation and inflammatory processes: A perspective. J Leukoc Biol 81:599–606.
25. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL. 2004. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126:1657–1664.
26. Cogan TA, Thomas AO, Rees LE, Taylor AH, Jepson MA, Williams PH, Ketley J, Humphrey TJ. 2007. Norepinephrine increases the pathogenic potential of Campylobacter jejuni. Gut 56:1060–1065.
27. Collins SM, Surette M, Bercik P. 2012. The interplay between the intestinal microbiota and the brain. Nature Rev Microbiol 10:735–742.
28. Corbillé AG, Clairembault T, Coron E, Leclair-Visonneau L, Preterre C, Neunlist M, Derkinderen P. 2016. What a gastrointestinal biopsy can tell us about Parkinson's disease? Neurogastroenterol Motil 28:966–974.
29. Cortese S, Gatta A, Della Valle L, Mangifesta R, Di Giampaolo L, Cavallucci E, Petrarca C, Paganelli R, Di Gioacchino M. 2016. Fluticasone/formoterol association favors long-lasting decrease in bronchial reactivity to methacholine and weekly PEF variability. Int J Immunopathol Pharmacol. In Press. doi 10.1177/0394632016650896
30. Costa M, Furness JB. 1976. The peristaltic reflex: An analysis of the nerve pathways and their pharmacology. Naunyn Schmiedebergs Arch Pharmacol 294:47–60.
31. Costedio MM, Coates MD, Danielson AB, Buttolph TR, 3rd, Blaszyk HJ, Mawe GM, Hyman NH. 2008. Serotonin signaling in diverticular disease. J Gastrointest Surg 12:1439–1445.
32. Crowell MD. 2004. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol 141:1285–1293.
33. Cryan JF, Kaupmann K. 2005. Don't worry ‘B’ happy!: A role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci 26:36–43.
34. Dall M, Schaffalitzky de Muckadell OB, Moller Hansen J, Wildner-Christensen M, Touborg Lassen A, Hallas J. 2011. Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors. Scand J Gastroenterol 46:1039–1044.
35. De Angelis M, Francavilla R, Piccolo M, De Giacomo A, Gobbetti M. 2015. Autism spectrum disorders and intestinal microbiota. Gut Microbes 6:207–213.
36. de Araujo IE, Oliveira-Maia AJ, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. 2008. Food reward in the absence of taste receptor signaling. Neuron 57:930–941.
37. del Rey A, Besedovsky HO. 2008. Sympathetic nervous system-immune interactions in autoimmune lymphoproliferative diseases. Neuroimmunomodulation 15:29–36.
38. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. 1990. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411–418.
39. Desbonnet L, Clarke G, Traplin A, O'Sullivan I, Crispie F, Moloney RD, Cotter PD, Dinan TG, Cryan JF. 2015. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun 48:165–173.
40. Di Sabatino A, Giuffrida P, Vanoli A, Luinetti O, Manca R, Biancheri P, Bergamaschi G, Alvisi C, Pasini A, Salvatore C, Biagi F, Solcia E, Corazza GR. 2014. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease. Am J Gastroenterol 109:258–269.
41. Diard S, Lievin-Le Moal V, Toribio AL, Boum Y, Vigier F, Servin AL, Bouvet O. 2009. Norepinephrine-dependently released Dr fimbriae of diffusely adhering Escherichia coli strain IH11128 promotes a mitogen-activated protein kinase ERK1/2-dependent production of pro-inflammatory cytokine, IL-8 in human intestinal Caco-2/TC7 cells. Microbes Infect 11:886–894.
42. Dickman R, Maradey-Romero C, Fass R. 2014. The role of pain modulators in esophageal disorders—No pain no gain. Neurogastroenterol Motil 26:603–610.
43. Diezmos EF, Bertrand PP, Liu L. 2016. Purinergic signaling in gut inflammation: The role of connexins and pannexins. Front Neurosci 10:311.
44. Doherty NC, Tobias A, Watson S, Atherton JC. 2009. The effect of the human gut-signalling hormone, norepinephrine, on the growth of the gastric pathogen Helicobacter pylori. Helicobacter 14:223–230.
45. Donowitz M. 1983. Ca2+ in the control of active intestinal Na and Cl transport: Involvement in neurohumoral action. Am J Physiol 245:165–177.
46. Dunn WR, Brock JA, Hardy TA. 1999. Electrochemical and electrophysiological characterization of neurotransmitter release from sympathetic nerves supplying rat mesenteric arteries. Br J Pharmacol 128:174–180.
47. Edgell H, Moore LE, Chung C, Byers BW, Stickland MK. 2016. Short-term cardiovascular and autonomic effects of inhaled salbutamol. Respir Physiol Neurobiol 231:14–20.
48. Ellermeier JR, Slauch JM. 2008. Fur regulates expression of the Salmonella pathogenicity island 1 type III secretion system through HilD. J Bacteriol 190:476–486.
49. Farache J, Koren I, Milo I, Gurevich I, Kim KW, Zigmond E, Furtado GC, Lira SA, Shakhar G. 2013. Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 38:581–595.
50. Feifel D, Shilling PD, Kuczenski R, Segal DS. 2003. Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats. Neurosci Lett 348:147–150.
51. Ferreira JG, Tellez LA, Ren X, Yeckel CW, de Araujo IE. 2012. Regulation of fat intake in the absence of flavour signalling. J Physiol 590:953–972.
52. Flemstrom G, Safsten B, Jedstedt G. 1993. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology 104:825–833.
53. Freestone PP, Lyte M, Neal CP, Maggs AF, Haigh RD, Williams PH. 2000. The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J Bacteriol 182:6091–6098.
54. Friedman M, Levin CE. 2012. Nutritional and medicinal aspects of D-amino acids. Amino Acids 42:1553–1582.
55. Gagon DJ. 1970. Intestinal smooth muscles: Demonstration of catecholamines-induced contraction mediated through alpha-adrenergic receptors. Eur J Pharmacol 10:297–300.
56. Gershon MD, Wade PR, Kirchgessner AL, Tamir H. 1990. 5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut. Neuropsychopharmacology 3:385–395.
57. Grayson J, Oyebola DD. 1983. The effect of catecholamines on intestinal glucose and oxygen uptake in the dog. J Physiol 343:311–322.
58. Grenham S, Clarke G, Cryan JF, Dinan TG. 2011. Brain-gut-microbe communication in health and disease. Front Physiol 2:94.
59. Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, Reis VO, Keller AC, Brum PC, Basso AS. 2013. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol 43:1001–1012.
60. Guseva D, Holst K, Kaune B, Meier M, Keubler L, Glage S, Buettner M, Bleich A, Pabst O, Bachmann O, Ponimaskin EG. 2014. Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract. Inflamm Bowel Dis 20:1516–1529.
61. Haas M, McBrayer D, Lytle C. 1995. [Cl-]i-dependent phosphorylation of the Na-K-Cl cotransport protein of dog tracheal epithelial cells. J Biol Chem 270:28955–28961.
62. Hannon J, Hoyer D. 2008. Molecular biology of 5-HT receptors. Behav Brain Res 195:198–213.
63. Hegde M, Wood TK, Jayaraman A. 2009. The neuroendocrine hormone norepinephrine increases Pseudomonas aeruginosa PA14 virulence through the las quorum-sensing pathway. Appl Microbiol Biotechnol 84:763–776.
64. 2C receptor agonists. Psychopharmacology (Berl) 233:2841–2856.
65. Hirst GD, Silinsky EM. 1975. Some effects of 5-hydroxytryptamine, dopamine and noradrenaline on neurones in the submucous plexus of guinea-pig small intestine. J Physiol 251:817–832.
66. Hoffman JM, Tyler K, MacEachern SJ, Balemba OB, Johnson AC, Brooks EM, Zhao H, Swain GM, Moses PL, Galligan JJ, Sharkey KA, Greenwood-Van Meerveld B, Mawe GM. 2012. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology 142:844–854.
67. Hoyer D, Hannon JP, Martin GR. 2002. Molecular, pharmacological adn functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554.
68. Ishikawa Y, Eguchi T, Ishida H. 1997. Mechanism of beta-adrenergic agonist-induced transmural transport of glucose in rat small intestine. Regulation of phosphorylation of SGLT1 controls the function. Biochim Biophys Acta 1357:306–318.
69. Isom LL, Cragoe EJ, Limbird LE. 1987. Alpha 2-adrenergic receptors accelerate Na+/H+ exchange in neuroblastoma X glioma cells. J Biol Chem 262:6750–6757.
70. Janig W. 2014. Sympathetic nervous system and inflammation: A conceptual view. Auton Neurosci 182:4–14.
71. Jeyarajah S, Akbar N, Moorhead J, Haji A, Banerjee S, Papagrigoriadis S. 2012. A clinicopathological study of serotonin of sigmoid colon mucosa in association with chronic symptoms in uncomplicated diverticulosis. Int J Colorectal Dis 27:1597–1607.
72. Ji XY, Wu M. 2016. MRNA expression of dopamine receptor D2 and dopamine transporter in peripheral blood lymphocytes before and after treatment in children with tic disorder. Zhongguo Dang Dai Er Ke Za Zhi 4:297–300.
73. Jiang Q, Lian A, He Q. 2016. Dopamine inhibits somatolactin gene expression in tilapia pituitary cells through the dopamine D2 receptors. Comp Biochem Physiol A Mol Integr Physiol 197:35–42.
74. Kamio Y, Saito Y, Utoguchi N, Kondoh M, Koizumi N, Fujii M, Watanabe Y. 2005. Epinephrine is an enhancer of rat intestinal absorption. J Control Release 102:563–568.
75. Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F. 2014. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Mol Cell Proteomics 5:1273–1285.
76. Karamanolis GP, Panapoulos S, Karlaftis A, Denaxas K, Kamberoglou D, Sifakakis PP, Ladas SD. 2015. Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study. United European Gastroenterol J 3:266–271.
77. Keszthelyi D, Troost FJ, Jonkers DM, Kruimel JW, Leue C, Masclee AA. 2013. Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: Relation to serotonin and psychological state. J Psychosom Res 74:501–504.
78. Keszthelyi D, Troost FJ, Jonkers DM, van Donkelaar EL, Dekker J, Buurmna WA, Masclee AA. 2012. Does acute tryptophan depletion affect peripheral serotonin metabolism in the intestine? Am J Clin Nutr 95:603–608.
79. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. 2009. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 21:439–450.
80. Kim T, Jwa CS. 2015. Effect of alpha-1-adrenergic agonist, midodrine for the management of long-standing neurogenic shock in patient with cervical spinal cord injury: A case report. Korean J Neurotrauma 2:147–150.
81. Kin NW, Sanders VM. 2006. It takes nerve to tell T and B cells what to do. J Leukoc Biol 79:1093–1104.
82. Kishi T, Meltzer HY, Matsuda Y, Iwata N. 2013. Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: Systematic review and meta-analysis. Psychol Med 11:2255–2269.
83. Knecht L, O'Connor G, Mittal R, Liu XZ, daftarian P, Deo SK, Daunert S. 2016. Serotonin activates bacterial quorum sensing and enhances the virulence of Pseudomonas aeruginosa in the host. EBioMedicine 9:161–169.
84. Krygowska-Wajs A, Furgala A, Gorecka-Mazur A, Pietraszko W, Thor P, Potasz-Kulikowska K, Moskala M. 2016. The effect of subthalamic deep brain stimulation on gastric motility in Parkinson's disease. Parkinsonism Relat Disord 26:35–40.
85. Kusunoki M, Taniyama K, Tanaka C. 1985. Dopamine regulation of [3H]acetylcholine release from guinea-pig stomach. J Pharmacol Exp Ther 234:713–719.
86. Le Floc'h N, Otten W, Merlot E. 2010. Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids 41:1195–1205.
87. Lefebvre RA, Van Colen I, Pauwelyn V, De Maeyer JH. 2016. Synergistic effect between 5-HT4 receptor agonist and phosphodiesterase 4-inhibitor in releasing acetylcholine in pig gastric circular muscle in vitro. Eur J Pharmacol 781:76–82.
88. Li B, Liu ML, Wu XP, Jia J, Cao J, Wei ZW, Wang YJ. 2015. Effects of ketamine exposure on dopamine concentrations and dopamine type 2 receptor mRNA expression in rat brain tissue. Int J Clin Exp Med 7:11181–11187.
89. Li W, Lyte M, Freestone PP, Ajmal A, Colmer-Hamood JA, Hamood AN. 2009. Norepinephrine represses the expression of toxA and the siderophore genes in Pseudomonas aeruginosa. FEMS Microbiol Lett 299:100–109.
90. Li ZS, Schmauss C, Cuenca A, Ratcliffe E, Gershon MD. 2006. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci 26:2798–2807.
91. Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F. 2015. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310:561–577.
92. Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. 2003. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J PHysiol Gastrointest Liver Physiol 235:207–216.
93. Liu YC, Chan KG, Chang CY. 2015. Modulation of host biology by Pseudomonas aeruginosa quorum sensing signal molecules: Messengers or traitors. Front Microbiol 6:1226.
94. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD. 2009. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29:9683–9699.
95. Lladó-Pelfort L, Troyano-Rodriguez E, van den Munkhof HE, Cervera-Ferri A, Jurado N, Núñez-Calvet M, Artigas F, Celada P. 2016. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands. Eur Neuropsychopharmacol 3:614–625.
96. Luo XJ, Zheng M, Tian G, Zhong HY, Zou XJ, Jian DL. 2016. Comparison of the treatment effects of methoxamine and combining methoxamine with atropine infusion to maintain blood pressure during spinal anesthesia for cesarean delivery: A double blind randomized trial. Eur Rev Med Pharmacol Sci 3:561–567.
97. Lyte M. 2004. Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol 12:14–20.
98. Lyte M. 2010. Microbial endocrinology as a basis for improved L-DOPA bioavailability in Parkinson's patients treated for Helicobacter pylori. Med Hypotheses 74:895–897.
99. Lyte M, Arulanandam B, Nguyen K, Frank C, Erickson A, Francis D. 1997. Norepinephrine induced growth and expression of virulence associated factors in enterotoxigenic and enterohemorrhagic strains of Escherichia coli. Adv Exp Med Biol 412:331–339.
100. Lyte M, Ernst S. 1992. Catecholamine induced growth of gram negative bacteria. Life Sci 50:203–212.
101. Lyte M, Frank CD, Green BT. 1996. Production of an autoinducer of growth by norepinephrine cultured Escherichia coli O157:H7. FEMS Microbiol Lett 139:155–159.
102. Macpherson AJ, Slack E. 2007. The functional interactions of commensal bacteria with intestinal secretory IgA. Curr Opin Gastroenterol 23:673–678.
103. Magro F, Vieira-Coelho MA, Fraga S, Serrão MP, Veloso FT, Ribeiro T, Soares-da-Silva P. 2002. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci 1:216–224.
104. Manivasagam S, Subramanian V, Tumala A, Vellaichamy E. 2016. Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during β-adrenergic receptor activation-induced hypertrophic growth in rats. Mol Cell Endocrinol 433:117–129.
105. Manoharan A, Morrison AE, Lipworth BJ. 2016. Effects of the inverse alpha-agonist doxazosin in allergic rhinitis. Clin Exp Allergy 5:696–704.
106. Mawe GM, Hoffman JM. 2013. Serotonin signaling in the gut—Functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 10:473–486.
107. McCullough LA, Westfall TC. 1996. Mechanism of catecholamine synthesis inhibition by neuropeptide Y: Role of Ca2+ channels and protein kinases. J Neurochem 67:1090–1099.
108. Mestecky J, Russell MW. 2009. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol Lett 124:57–62.
109. Minderhoud IM, Oldenburg B, Schipper ME, Ter Linde JJ, Samsom M. 2007. Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin Gastroenterol Hepatol 5:714–720.
110. Monro RL, Bertrand PP, Bornstein JC. 2004. ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the Guinea pig ileum. J Physiol 556:571–584.
111. Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K. 2016. Microbiota and neurological disorders: A gut feeling. Biores Open Access 5:137–145.
112. Moreira CG, Weinshenker D, Sperandio V. 2010. QseC mediates Salmonella enterica serovar typhimurium virulence in vitro and in vivo. Infect Immun 78:914–926.
113. Nakamura K, Sato T, Ohashi A, Tsurui H, Hasegawa H. 2008. Role of a serotonin precursor in development of gut microvilli. Am J Pathol 172:333–344.
114. Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F. 2008. Parkinson's disease and the gut: A well-known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil 7:741–749.
115. Neal KB, Bornstein JC. 2006. Serotonergic receptors in therapeutic approaches to gastrointestinal disorders. Curr Opin Pharmacol 6:547–552.
116. Nilssen DE, Oktedalen O, Lygren I, Opstad PK, Brandtzaeg P. 1998. Intestinal IgA- and IgM-producing cells are not decreased in marathon runners. Int J Sports Med 19:425–431.
117. Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, Sano Y, Inamura K, Matsushime H, Koizumi T, Yokoyama T, Ito H. 2009. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci USA 106:3408–3413.
118. O'Hara JR, Skinn AC, MacNaughton WK, Sherman PM, Sharkey KA. 2006. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 8:646–660.
119. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. 2015. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32–48.
120. Olaleye SB, Elegbe RA. 2005. Catecholamines potentiate the effect of thyroid hormone on intestinal absorption of glucose in the rat. Afr J Med Med Sci 34:177–183.
121. Ostovaneh MR, Saeidi B, Hajifathalian K, Farrokhi-Khajeh-Pasha Y, Fotouhi A, Mirbagheri SS, Emami H, Barzin G, Mirbagheri SA. 2014. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebo-controlled trial. Neurogastroenterol Motil 26:670–678.
122. Palacios JM. 2016. Serotonin receptors in brain revisited. Brain Res 1645:46–49.
123. Rang C, Galen JE, Kaper JB, Chao L. 2003. Fitness cost of the green fluorescent protein in gastrointestinal bacteria. Can J Microbiol 49:531–537.
124. Rapalli A, Bertoni S, Arcaro V, Saccani F, Grandi A, Vivo V, Cantoni AM, Barocelli E. 2016. Dual role of endogenous serotonin in 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Front Pharmacol 7:68.
125. Reber SO. 2012. Stress and animal models of inflammatory bowel disease—An update on the role of the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology 37:1–19.
126. Ren J, Bertrand PP. 2008. Purinergic receptors and synaptic transmission in enteric neurons. Purinergic Signal 4:255–266.
127. Ren X, Ferreira JG, Zhou L, Shammah-Lagnado SJ, Yeckel CW, de Araujo IE. 2010. Nutrient selection in the absence of taste receptor signaling. J Neurosci 30:8012–8023.
128. Reyna-Garfias H, Miliar A, Jarillo-Luna A, Rivera-Aguilar V, Pacheco-Yepez J, Baeza I, Campos-Rodriguez R. 2010. Repeated restraint stress increases IgA concentration in rat small intestine. Brain Behav Immun 24:110–118.
129. Rhee SH, Pothoulakis C, Mayer EA. 2009. Principles and clinical implication of the brain-gut-enteric microbiota axis. Nature Rev Gastroentrol Hepatic 6:304–314.
130. Richardson PD, Withrington PG. 1982. Physiological regulation of the hepatic circulation. Annu Rev Physiol 44:57–69.
131. Rosenfeld CS. 2015. Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos 43:1557–1571.
132. Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. 2006. Tryptophan metabolism in the central nervous system: Medical implications. Expert Rev Mol Med 8:1–27.
133. Sander CY, Hooker JM, Catana C, Rosen BR, Mandeville JB. 2016. Imaging agonist-induced D2/D3 receptor desensitization and internalization in vivo with PET/FMRI. Neuropsychopharmacology 5:1427–1436.
134. Sartre RB. 2006. Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390–407.
135. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. 2002. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 4:1140–1154.
136. Scheerens C, Tack J, Rommel N. 2015. Buspirone, a new drug for the management of patients with ineffective esophageal motility. United European Gastroenterol J 3:261–265.
137. Schwarcsz R, Bruno JP, Muchowski PJ, Wu HQ. 2012. Kynurenines in the mammalian brain: When physiology meets pathology. Nat Reve Neurosci 13:465–477.
138. Sclafani A. 2001. Post-ingestive positive controls of ingestive behavior. Appetite 36:79–83.
139. Seifi M, Brown JF, Mills J, Bhandari P, Belelli D, Lambert JJ, Rudolph U, Swinny JD. 2014. Molecular and functional diversity of GABA-A receptors in the enteric nervous system of the mouse colon. J Neurosci 34:10361–10378.
140. Shanahan F. 2002. Gut flora in gastrointestinal disease. Eur J Surg Suppl 587:47–52.
141. Shaw SY, Blanchard JF, Berstein CN. 2010. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 105:2687–2692.
142. Shelkar GP, Gakare SG, Chakraborty S, Dravid SM, Ugale RR. 2016. Nitric oxide-α2−adrenergic receptor interaction within locus coeruleus underlies facilitation of inhibitory avoidance memory by agmatine. Br J Pharmacol 173:2589–2599.
143. Shiman R, Akino M, Kaufman S. 1971. Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem 246:1330–1340.
144. Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EM. 1995. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 8979:861–864.
145. Skowronski MT, Ishikawa Y, Ishida H. 2000. Enhancement by epinephrine of benzylpenicillin transport in rat small intestine. J Pharmacol Exp Ther 293:128–135.
146. Smith EA, Macfarlane GT. 1997. Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe 3:327–337.
147. Sugama S, Kakinuma Y. 2016. Loss of dopaminergic neurons occurs in the ventral tegmental area and hypothalamus of rats following chronic stress: Possible pathogenetic loci for depression involved in Parkinson's disease. Neurosci Res 16:30048–30047.
148. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J. 2001. Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98:9983–9988.
149. Tache Y, Martinez V, Million M, Wang L. 2001. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: Role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 280:173–177.
150. Thompson MA, Woolley DE, Gietzen DW, Conway S. 1983. Catecholamine synthesis inhibitors acutely modulate [3H]estradiol binding by specific brain areas and pituitary in ovariectomized rats. Endocrinology 113:855–865.
151. Tian J, Chau C, Hales TG, Kaufman DL. 1999. GABA(A) receptors mediate inhibition of T cell responses. J Neuroimmunol 96:21–28.
152. Tolstanova G, Deng X, Ahluwalia A, Paunovic B, Prysiazhniuk A, Ostapchenko L, Tarnawski A, Sandor Z, Szabo S. 2015. Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatory bowel disease. Dig Dis Sci 10:2963–2975.
153. Toti L, Travagli RA, Am J. 2014. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis. Physiol Gastrointest Liver Physiol 10:1013–1023.
154. Umesaki Y, Okada Y, Matsumoto S, Imaoka A, Setoyama H. 1995. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol Immunol 39:555–562.
155. Vanuytsel T, Tack JF, Boeckxstaens GE. 2014. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol 49:1193–1205.
156. Vécsei L, Szalárdy L, Fülöp F, Toldi J. 2013. Kynurenines in the CNS: Recent advances and new questions. Nat Reve Drug Discov 12:64–82.
157. Viazis N, Karamanolis G, Vienna E, Karamanolis DG. 2011. Selective-serotonin reuptake inhibitors for the treatment of hypersensitive esophagus. Therap Adv Gastroenterol 4:295–300.
158. Viazis N, Keyoglou A, Kanellopoulos AK, Karamanoulis G, Vlachogiannakos J, Triantafyllou K, Ladas SD, Karamanolis DG. 2012. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: A randomized, double-blind, placebo-controlled study. Am J Gastroenterol 107:1662–1667.
159. Vieira-Coelho MA, Teixeira VA, Finkel Y, Soares-Da-Silva P, Bertorello AM. 1998. Dopamine-dependent inhibition of jejunal Na+-K+-ATPase during high-salt diet in young but not in adult rats. Am J Physiol 275:1317–1323.
160. Vizi ES, Elenkov IJ. 2002. Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung 53:229–244.
161. Wang YP, Chen YT, Tsai CF, Li SY, Luo JC, Wang SJ, Tang CH, Liu CJ, Lin HC, Lee FY, Chang FY, Lu CL. 2014. Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry 171:54–61.
162. Watson DJ, King MV, Gyertyán I, Kiss B, Adham N, Fone KC. 2015. The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia. Eur Neuropsychopharmacol 2:208–224.
163. West AB. 2008. The pathology of diverticulitis. J Clin Gastroenterol 42:1137–1138.
164. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. 2005. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 17:863–870.
165. Wirth A, Holst K, Ponimaskin E. 2016. How serotonin receptors regulate morphogenic signalling in neurons. Prog Neurobiol. In Press. doi: 10.1016/j.pneurobio.2016.03.007
166. Wostmann BS, Pleasants JR, Bealmear P, Kincade PW. 1970. Serum proteins and lymphoid tissues in germ-free mice fed a chemically defined, water soluble, low molecular weight diet. Immunology 19:443–448.
167. Wu L, Oshima T, Tomita T, Ohda Y, Fukui H, Watari J, Miwa H. 2016. Serotonin disrupts esophageal mucosal integrity: An investigation using a stratified squamous epithelial model. J Gastroenterol. In Press. doi: 10.1007/s00535-016-1195-z
168. Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB. 2016. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis. World J Gastroetnerol 22:3451–3459.
169. Zang KH, Shao YY, Zuo X, Rao Z, Qin HY. 2016. Oridonin alleviates visceral hyperalgesia in a rat model of postinflammatory irritable bowel syndrome: Role of colonic enterochromaffin cell and serotonin availability. J Med Food 19:586–592.